10 20 30 40 50 60 70 80 1ZY4 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 09-JUN-05 1ZY4
TITLE CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: R794G TITLE 2 HYPERACTIVATING MUTANT IN APO FORM.
COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE GCN2; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.7.1.37; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 GENE: GCN2, AAS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET26B
KEYWDS TRANSLATION REGULATOR, PROTEIN KINASE, SIGNAL TRANSDUCTION, AMINO- KEYWDS 2 ACID STARVATION, STARVATION STRESS RESPONSE, EIF2ALPHA KINASE, KEYWDS 3 TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR A.K.PADYANA,H.QIU,A.ROLL-MECAK,A.G.HINNEBUSCH,S.K.BURLEY
REVDAT 4 13-JUL-11 1ZY4 1 VERSN REVDAT 3 24-FEB-09 1ZY4 1 VERSN REVDAT 2 16-AUG-05 1ZY4 1 JRNL REVDAT 1 21-JUN-05 1ZY4 0
JRNL AUTH A.K.PADYANA,H.QIU,A.ROLL-MECAK,A.G.HINNEBUSCH,S.K.BURLEY JRNL TITL STRUCTURAL BASIS FOR AUTOINHIBITION AND MUTATIONAL JRNL TITL 2 ACTIVATION OF EUKARYOTIC INITIATION FACTOR 2{ALPHA} PROTEIN JRNL TITL 3 KINASE GCN2 JRNL REF J.BIOL.CHEM. V. 280 29289 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15964839 JRNL DOI 10.1074/JBC.M504096200
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.QIU,C.HU,J.DONG,A.G.HINNEBUSCH REMARK 1 TITL MUTATIONS THAT BYPASS TRNA BINDING ACTIVATE THE REMARK 1 TITL 2 INTRINSICALLY DEFECTIVE KINASE DOMAIN IN GCN2. REMARK 1 REF GENES DEV. V. 16 1271 2002 REMARK 1 REFN ISSN 0890-9369
REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,MOLECULAR REMARK 3 : SIMULATIONS (BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1973272.770 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 45110 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SHELLS REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1407 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 45568 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6816 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 229 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4293 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 234 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.68000 REMARK 3 B22 (A**2) : -5.01000 REMARK 3 B33 (A**2) : 0.33000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.25 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.77 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.090 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.300 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.450 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.970 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 60.67 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : GOL_PAR.TXT REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : &_1_TOPOLOGY_INFILE_2 REMARK 3 TOPOLOGY FILE 3 : &_1_TOPOLOGY_INFILE_3 REMARK 3 TOPOLOGY FILE 4 : GOL_TOP.TXT REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1ZY4 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUN-05. REMARK 100 THE RCSB ID CODE IS RCSB033255.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-AUG-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97931 REMARK 200 MONOCHROMATOR : DIAMOND 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45176 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 9.900 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.66000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP, CCP4 REMARK 200 STARTING MODEL: 1ZYC REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, CHES, PH 9.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 295K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.41650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.43150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.62850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 73.43150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.41650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.62850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY OF GCN2 PROTEIN KINASE IS A DIMER. REMARK 300 THE ASYMMETRIC UNIT OF THIS CRYSTAL LATTICE CONTAINS ONE DIMER REMARK 300 ASSEMBLED INTO ONE BIOLOGICAL UNIT.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 773 REMARK 465 PRO A 774 REMARK 465 MET A 775 REMARK 465 THR A 776 REMARK 465 ALA A 777 REMARK 465 VAL A 778 REMARK 465 SER A 863 REMARK 465 LEU A 864 REMARK 465 ASP A 865 REMARK 465 ILE A 866 REMARK 465 LEU A 867 REMARK 465 LYS A 868 REMARK 465 LEU A 869 REMARK 465 ASP A 870 REMARK 465 SER A 871 REMARK 465 GLN A 872 REMARK 465 ASN A 873 REMARK 465 LEU A 874 REMARK 465 PRO A 875 REMARK 465 GLY A 876 REMARK 465 SER A 877 REMARK 465 SER A 878 REMARK 465 ASP A 879 REMARK 465 ASN A 880 REMARK 465 LEU A 881 REMARK 465 THR A 882 REMARK 465 SER A 883 REMARK 465 ALA A 884 REMARK 465 ILE A 885 REMARK 465 GLY A 886 REMARK 465 THR A 887 REMARK 465 LEU A 997 REMARK 465 LYS B 773 REMARK 465 PRO B 774 REMARK 465 MET B 775 REMARK 465 THR B 776 REMARK 465 ALA B 777 REMARK 465 VAL B 778 REMARK 465 LYS B 779 REMARK 465 ALA B 857 REMARK 465 LYS B 858 REMARK 465 ASN B 859 REMARK 465 VAL B 860 REMARK 465 HIS B 861 REMARK 465 ARG B 862 REMARK 465 SER B 863 REMARK 465 LEU B 864 REMARK 465 ASP B 865 REMARK 465 ILE B 866 REMARK 465 LEU B 867 REMARK 465 LYS B 868 REMARK 465 LEU B 869 REMARK 465 ASP B 870 REMARK 465 SER B 871 REMARK 465 GLN B 872 REMARK 465 ASN B 873 REMARK 465 LEU B 874 REMARK 465 PRO B 875 REMARK 465 GLY B 876 REMARK 465 SER B 877 REMARK 465 SER B 878 REMARK 465 ASP B 879 REMARK 465 ASN B 880 REMARK 465 LEU B 881 REMARK 465 THR B 882 REMARK 465 SER B 883 REMARK 465 ALA B 884 REMARK 465 ASP B 897 REMARK 465 GLY B 898 REMARK 465 THR B 899 REMARK 465 GLY B 900 REMARK 465 HIS B 901 REMARK 465 LYS B 984 REMARK 465 HIS B 985 REMARK 465 GLN B 986 REMARK 465 ASP B 987 REMARK 465 GLU B 988 REMARK 465 VAL B 989 REMARK 465 ILE B 990 REMARK 465 LYS B 991 REMARK 465 GLU B 992 REMARK 465 ALA B 993 REMARK 465 LEU B 994 REMARK 465 LYS B 995 REMARK 465 SER B 996 REMARK 465 LEU B 997
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 126 O HOH A 224 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 808 72.85 -100.47 REMARK 500 ARG A 834 -18.97 79.73 REMARK 500 LEU A 896 -76.15 -60.90 REMARK 500 THR A 899 -119.38 -74.15 REMARK 500 GLN B 612 171.95 169.49 REMARK 500 SER B 622 -1.44 68.11 REMARK 500 HIS B 632 -175.24 -175.10 REMARK 500 ASN B 770 -9.57 -55.41 REMARK 500 GLN B 808 79.30 -113.47 REMARK 500 ARG B 834 -14.20 77.58 REMARK 500 ASP B 835 40.60 -143.69 REMARK 500 ASP B 947 81.80 -49.64 REMARK 500 ASN B 949 -72.46 -101.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 624 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 233 DISTANCE = 6.26 ANGSTROMS
REMARK 600 REMARK 600 HETEROGEN REMARK 600 GOL 997 IS ASSOCIATED WITH PROTEIN CHAIN A. REMARK 600 GOL 998 IS ASSOCIATED WITH PROTEIN CHAIN B.
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 998 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 998
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZY5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: R794G REMARK 900 HYPERACTIVATING MUTANT COMPLEXED WITH AMPPNP. REMARK 900 RELATED ID: 1ZYC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: WILD- REMARK 900 TYPE IN APO FORM. REMARK 900 RELATED ID: 1ZYD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: WILD- REMARK 900 TYPE COMPLEXED WITH ATP. REMARK 900 RELATED ID: 1ZXE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: D835N REMARK 900 INACTIVATING MUTANT IN APO FORM.
DBREF 1ZY4 A 594 664 UNP P15442 GCN2_YEAST 525 595 DBREF 1ZY4 B 594 664 UNP P15442 GCN2_YEAST 525 595 DBREF 1ZY4 A 768 997 UNP P15442 GCN2_YEAST 699 928 DBREF 1ZY4 B 768 997 UNP P15442 GCN2_YEAST 699 928
SEQADV 1ZY4 SER A 592 UNP P15442 CLONING ARTIFACT SEQADV 1ZY4 LEU A 593 UNP P15442 CLONING ARTIFACT SEQADV 1ZY4 GLY A 794 UNP P15442 ARG 725 ENGINEERED SEQADV 1ZY4 SER B 592 UNP P15442 CLONING ARTIFACT SEQADV 1ZY4 LEU B 593 UNP P15442 CLONING ARTIFACT SEQADV 1ZY4 GLY B 794 UNP P15442 ARG 725 ENGINEERED
SEQRES 1 A 303 SER LEU ARG TYR ALA SER ASP PHE GLU GLU ILE ALA VAL SEQRES 2 A 303 LEU GLY GLN GLY ALA PHE GLY GLN VAL VAL LYS ALA ARG SEQRES 3 A 303 ASN ALA LEU ASP SER ARG TYR TYR ALA ILE LYS LYS ILE SEQRES 4 A 303 ARG HIS THR GLU GLU LYS LEU SER THR ILE LEU SER GLU SEQRES 5 A 303 VAL MET LEU LEU ALA SER LEU ASN HIS GLN TYR VAL VAL SEQRES 6 A 303 ARG TYR TYR ALA ALA TRP LEU GLU ARG ARG ASN PHE VAL SEQRES 7 A 303 LYS PRO MET THR ALA VAL LYS LYS LYS SER THR LEU PHE SEQRES 8 A 303 ILE GLN MET GLU TYR CYS GLU ASN GLY THR LEU TYR ASP SEQRES 9 A 303 LEU ILE HIS SER GLU ASN LEU ASN GLN GLN ARG ASP GLU SEQRES 10 A 303 TYR TRP ARG LEU PHE ARG GLN ILE LEU GLU ALA LEU SER SEQRES 11 A 303 TYR ILE HIS SER GLN GLY ILE ILE HIS ARG ASP LEU LYS SEQRES 12 A 303 PRO MET ASN ILE PHE ILE ASP GLU SER ARG ASN VAL LYS SEQRES 13 A 303 ILE GLY ASP PHE GLY LEU ALA LYS ASN VAL HIS ARG SER SEQRES 14 A 303 LEU ASP ILE LEU LYS LEU ASP SER GLN ASN LEU PRO GLY SEQRES 15 A 303 SER SER ASP ASN LEU THR SER ALA ILE GLY THR ALA MET SEQRES 16 A 303 TYR VAL ALA THR GLU VAL LEU ASP GLY THR GLY HIS TYR SEQRES 17 A 303 ASN GLU LYS ILE ASP MET TYR SER LEU GLY ILE ILE PHE SEQRES 18 A 303 PHE GLU MET ILE TYR PRO PHE SER THR GLY MET GLU ARG SEQRES 19 A 303 VAL ASN ILE LEU LYS LYS LEU ARG SER VAL SER ILE GLU SEQRES 20 A 303 PHE PRO PRO ASP PHE ASP ASP ASN LYS MET LYS VAL GLU SEQRES 21 A 303 LYS LYS ILE ILE ARG LEU LEU ILE ASP HIS ASP PRO ASN SEQRES 22 A 303 LYS ARG PRO GLY ALA ARG THR LEU LEU ASN SER GLY TRP SEQRES 23 A 303 LEU PRO VAL LYS HIS GLN ASP GLU VAL ILE LYS GLU ALA SEQRES 24 A 303 LEU LYS SER LEU SEQRES 1 B 303 SER LEU ARG TYR ALA SER ASP PHE GLU GLU ILE ALA VAL SEQRES 2 B 303 LEU GLY GLN GLY ALA PHE GLY GLN VAL VAL LYS ALA ARG SEQRES 3 B 303 ASN ALA LEU ASP SER ARG TYR TYR ALA ILE LYS LYS ILE SEQRES 4 B 303 ARG HIS THR GLU GLU LYS LEU SER THR ILE LEU SER GLU SEQRES 5 B 303 VAL MET LEU LEU ALA SER LEU ASN HIS GLN TYR VAL VAL SEQRES 6 B 303 ARG TYR TYR ALA ALA TRP LEU GLU ARG ARG ASN PHE VAL SEQRES 7 B 303 LYS PRO MET THR ALA VAL LYS LYS LYS SER THR LEU PHE SEQRES 8 B 303 ILE GLN MET GLU TYR CYS GLU ASN GLY THR LEU TYR ASP SEQRES 9 B 303 LEU ILE HIS SER GLU ASN LEU ASN GLN GLN ARG ASP GLU SEQRES 10 B 303 TYR TRP ARG LEU PHE ARG GLN ILE LEU GLU ALA LEU SER SEQRES 11 B 303 TYR ILE HIS SER GLN GLY ILE ILE HIS ARG ASP LEU LYS SEQRES 12 B 303 PRO MET ASN ILE PHE ILE ASP GLU SER ARG ASN VAL LYS SEQRES 13 B 303 ILE GLY ASP PHE GLY LEU ALA LYS ASN VAL HIS ARG SER SEQRES 14 B 303 LEU ASP ILE LEU LYS LEU ASP SER GLN ASN LEU PRO GLY SEQRES 15 B 303 SER SER ASP ASN LEU THR SER ALA ILE GLY THR ALA MET SEQRES 16 B 303 TYR VAL ALA THR GLU VAL LEU ASP GLY THR GLY HIS TYR SEQRES 17 B 303 ASN GLU LYS ILE ASP MET TYR SER LEU GLY ILE ILE PHE SEQRES 18 B 303 PHE GLU MET ILE TYR PRO PHE SER THR GLY MET GLU ARG SEQRES 19 B 303 VAL ASN ILE LEU LYS LYS LEU ARG SER VAL SER ILE GLU SEQRES 20 B 303 PHE PRO PRO ASP PHE ASP ASP ASN LYS MET LYS VAL GLU SEQRES 21 B 303 LYS LYS ILE ILE ARG LEU LEU ILE ASP HIS ASP PRO ASN SEQRES 22 B 303 LYS ARG PRO GLY ALA ARG THR LEU LEU ASN SER GLY TRP SEQRES 23 B 303 LEU PRO VAL LYS HIS GLN ASP GLU VAL ILE LYS GLU ALA SEQRES 24 B 303 LEU LYS SER LEU
HET GOL A 998 6 HET GOL B 998 6
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 3 GOL 2(C3 H8 O3) FORMUL 5 HOH *234(H2 O)
HELIX 1 1 LEU A 593 ASP A 598 1 6 HELIX 2 2 GLU A 634 ALA A 648 1 15 HELIX 3 3 THR A 795 GLU A 803 1 9 HELIX 4 4 ASN A 804 GLN A 807 5 4 HELIX 5 5 GLN A 808 GLN A 829 1 22 HELIX 6 6 LYS A 837 MET A 839 5 3 HELIX 7 7 ALA A 892 ASP A 897 1 6 HELIX 8 8 GLU A 904 TYR A 920 1 17 HELIX 9 9 THR A 924 SER A 937 1 14 HELIX 10 10 MET A 951 ILE A 962 1 12 HELIX 11 11 ASP A 965 ARG A 969 5 5 HELIX 12 12 GLY A 971 SER A 978 1 8 HELIX 13 13 HIS A 985 SER A 996 1 12 HELIX 14 14 LEU B 593 ASP B 598 1 6 HELIX 15 15 THR B 633 SER B 638 1 6 HELIX 16 16 ILE B 640 ALA B 648 1 9 HELIX 17 17 THR B 795 HIS B 801 1 7 HELIX 18 18 ASN B 804 GLN B 807 5 4 HELIX 19 19 GLN B 808 GLN B 829 1 22 HELIX 20 20 THR B 887 VAL B 891 5 5 HELIX 21 21 GLU B 904 TYR B 920 1 17 HELIX 22 22 THR B 924 SER B 937 1 14 HELIX 23 23 MET B 951 ILE B 962 1 12 HELIX 24 24 ASP B 965 ARG B 969 5 5 HELIX 25 25 GLY B 971 GLY B 979 1 9
SHEET 1 A 5 PHE A 599 GLN A 607 0 SHEET 2 A 5 GLY A 611 ASN A 618 -1 O LYS A 615 N ALA A 603 SHEET 3 A 5 TYR A 624 THR A 633 -1 O ILE A 627 N VAL A 614 SHEET 4 A 5 LYS A 781 GLU A 789 -1 O MET A 788 N ALA A 626 SHEET 5 A 5 TYR A 658 GLU A 664 -1 N TRP A 662 O PHE A 785 SHEET 1 B 2 ILE A 841 ILE A 843 0 SHEET 2 B 2 VAL A 849 ILE A 851 -1 O LYS A 850 N PHE A 842 SHEET 1 C 5 PHE B 599 GLN B 607 0 SHEET 2 C 5 GLY B 611 ASN B 618 -1 O LYS B 615 N ILE B 602 SHEET 3 C 5 TYR B 624 HIS B 632 -1 O ILE B 627 N VAL B 614 SHEET 4 C 5 SER B 782 GLU B 789 -1 O MET B 788 N ALA B 626 SHEET 5 C 5 TYR B 658 GLU B 664 -1 N ALA B 660 O GLN B 787 SHEET 1 D 2 ILE B 841 ILE B 843 0 SHEET 2 D 2 VAL B 849 ILE B 851 -1 O LYS B 850 N PHE B 842
SITE 1 AC1 6 HOH A 9 VAL A 656 GLU A 789 TYR A 790 SITE 2 AC1 6 CYS A 791 ASP A 853 SITE 1 AC2 6 HOH B 50 GLU B 789 TYR B 790 CYS B 791 SITE 2 AC2 6 PHE B 842 ASP B 853
CRYST1 52.833 79.257 146.863 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018928 0.000000 0.000000 0.00000
SCALE2 0.000000 0.012617 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006809 0.00000